BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 25449710)

  • 1. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses.
    Takahashi H; Rissling AJ; Pascual-Marqui R; Kirihara K; Pela M; Sprock J; Braff DL; Light GA
    Neuroimage; 2013 Feb; 66():594-603. PubMed ID: 23085112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia.
    Rissling AJ; Miyakoshi M; Sugar CA; Braff DL; Makeig S; Light GA
    Neuroimage Clin; 2014; 6():424-37. PubMed ID: 25379456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2.
    Turetsky BI; Dress EM; Braff DL; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Light G
    Schizophr Res; 2015 Apr; 163(1-3):53-62. PubMed ID: 25306203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.
    Hamilton HK; Perez VB; Ford JM; Roach BJ; Jaeger J; Mathalon DH
    Schizophr Bull; 2018 Apr; 44(3):492-504. PubMed ID: 29036701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory event-related potentials, neurocognition, and global functioning in drug naïve first-episode schizophrenia and bipolar disorder.
    Li X; Deng W; Xue R; Wang Q; Ren H; Wei W; Zhang Y; Li M; Zhao L; Du X; Meng Y; Ma X; Hall MH; Li T
    Psychol Med; 2023 Feb; 53(3):785-794. PubMed ID: 34474699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.
    Rissling AJ; Park SH; Young JW; Rissling MB; Sugar CA; Sprock J; Mathias DJ; Pela M; Sharp RF; Braff DL; Light GA
    Schizophr Res; 2013 May; 146(1-3):326-35. PubMed ID: 23490760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis.
    Mondragón-Maya A; Solís-Vivanco R; León-Ortiz P; Rodríguez-Agudelo Y; Yáñez-Téllez G; Bernal-Hernández J; Cadenhead KS; de la Fuente-Sandoval C
    J Psychiatr Res; 2013 Jun; 47(6):755-61. PubMed ID: 23507048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia.
    Jahshan C; Wynn JK; Mathis KI; Altshuler LL; Glahn DC; Green MF
    Bipolar Disord; 2012 May; 14(3):239-48. PubMed ID: 22548897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Smith DM; Labelle A; Knott VJ
    Biol Psychol; 2014 Jul; 100():43-9. PubMed ID: 24865523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic sensory information processing abnormalities across the illness course of schizophrenia.
    Jahshan C; Cadenhead KS; Rissling AJ; Kirihara K; Braff DL; Light GA
    Psychol Med; 2012 Jan; 42(1):85-97. PubMed ID: 21740622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.
    Perez VB; Tarasenko M; Miyakoshi M; Pianka ST; Makeig SD; Braff DL; Swerdlow NR; Light GA
    Neuropsychopharmacology; 2017 Oct; 42(11):2206-2213. PubMed ID: 28139679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.
    Hochberger WC; Joshi YB; Zhang W; Thomas ML; ; Braff DL; Swerdlow NR; Light GA
    Int J Psychophysiol; 2019 Nov; 145():23-29. PubMed ID: 30586570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication.
    Kruiper C; Glenthøj BY; Oranje B
    Neuropsychopharmacology; 2019 May; 44(6):1062-1067. PubMed ID: 30797222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal auditory pattern perception in schizophrenia.
    Haigh SM; Coffman BA; Murphy TK; Butera CD; Salisbury DF
    Schizophr Res; 2016 Oct; 176(2-3):473-479. PubMed ID: 27502427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.